Author:
Gedam Dilip S,Madkey Madhavi Vijaykumar,Meshram Vinay M,Gajbhiye Swati B
Abstract
Dengue is a vector-borne disease that is a major public health threat globally affecting three billion people with approximately 200 million cases of morbidity and 50,000 cases of mortality annually. It is transmitted to humans by Aedes mosquitoes. It is caused by the dengue virus (DENV, 1–4 serotypes). The clinical manifestations of dengue vary from mild fever to severe hemorrhage, shock, and death. It is critical to make an early and accurate laboratory diagnosis of DENV infection for effective patient management. Dengue is now no more restricted to the urban population, it has become endemic in the rural population as well. 1. To find the seroprevalence of dengue virus infection in the tribal population of Gondia district. 2. To observe the seasonal variation of dengue cases. This study was conducted under the NVBDC program at the Department of Microbiology, GMC, Gondia which is the sentinel center for Dengue and Chikungunya. The Study was carried out from October 2018 to September 2020. Serum samples of patients with dengue-like clinical illness were subjected to IgM antibody detection by dengue MAC ELISA. Seroprevalence of dengue in Gondia was found to be 12.37% (48/388). The most common age group affected was 21-30 years (39.59%). Males (54.17%) were affected more than females (45.83%). The peak of dengue cases was observed in September 2019. Less number of cases were reported in the year 2020.Newer diagnostic techniques, public awareness programs, better education, and proper monitoring of vector control are required to prevent dengue outbreaks.
Publisher
IP Innovative Publication Pvt Ltd
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference22 articles.
1. Tchuandom SB, Tchadji JC, Tchouangueu TF, Biloa MZ, Atabonkeng EP, Fumba MIM, A cross-sectional study of acute dengue infection in paediatric clinics in Cameroon.BMC Public Health 2019;19:958
2. Deshkar ST, Raut SS, Khadse RK, Dengue infection in central India: a 5 years study at a tertiary care hospital.Int J Res Med Sci 2017;5(6):2483-9
3. Singh M, The epidemiology of dengue viral infection in developing countries: A systematic review.J Health Res Rev 2017;4:104-7
4. World Health Organization. Geneva, Switzerland: WHO. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. 2009..
5. National Vector Borne Disease Control Program. Directorate General of Health Services Ministry of Health and Family Welfare, Government of India, 2019 report..
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献